TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2671692
log Bayes Factor = <0.0001
Chromosome 10   position 50,097,819  (GRCh37) Explore rs2671692 on Ensembl!
Variant rs2671692 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Y42.5 Other oestrogens and progestogens
0.000 0.944 0.056
Y45.0 Opioids and related analgesics
0.000 0.946 0.054
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.947 0.053
M48.02 Spinal stenosis (Cervical region)
0.000 0.948 0.052
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.948 0.052
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.950 0.050
H53.2 Diplopia
0.046 0.954 0.000
Y45.1 Salicylates
0.000 0.954 0.046
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.955 0.045
Y45.2 Propionic acid derivatives
0.000 0.956 0.044
Y42.7 Androgens and anabolic congeners
0.000 0.959 0.041
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.961 0.039
Y42.9 Other and unspecified hormone antagonists
0.000 0.961 0.039
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.962 0.038
Y45.4 Antirheumatics
0.000 0.962 0.038
Y42.4 Oral contraceptives
0.000 0.963 0.037
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.963 0.037
Y45.5 4-Aminophenol derivatives
0.000 0.967 0.033
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.968 0.032
Y42.1 Thyroid hormones and substitutes
0.000 0.969 0.031
Y45.8 Other analgesics and antipyretics
0.000 0.969 0.031
Y42.2 Antithyroid drugs
0.000 0.969 0.031
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.970 0.030
Y52 Agents primarily affecting the cardiovascular system
0.000 0.973 0.027
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.973 0.027
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.974 0.026
Y48 Anaesthetics and therapeutic gases
0.000 0.974 0.026
Y58 Bacterial vaccines
0.000 0.975 0.025
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.975 0.025
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.976 0.024
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.976 0.024
Y52.1 Calcium-channel blockers
0.000 0.976 0.024
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.976 0.024
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.977 0.023
Z45.2 Adjustment and management of vascular access device
0.000 0.977 0.023
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.977 0.023
Y59 Other and unspecified vaccines and biological substances
0.000 0.978 0.021
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.979 0.021
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.979 0.021
Y48.3 Local anaesthetics
0.000 0.979 0.021
Y49.5 Other antipsychotics and neuroleptics
0.000 0.979 0.021
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.979 0.021
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.979 0.021
Y48.2 Other and unspecified general anaesthetics
0.000 0.979 0.021
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.979 0.021
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.979 0.021
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.979 0.020
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.980 0.020
Y52.7 Peripheral vasodilators
0.000 0.980 0.020
Y58.0 BCG vaccine
0.000 0.980 0.020
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.980 0.020
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.980 0.020
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.980 0.020
Y47.1 Benzodiazepines
0.000 0.981 0.019
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.981 0.019
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.019
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.981 0.019
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.981 0.019
Y51.0 Anticholinesterase agents
0.000 0.981 0.019
Y54.3 Benzothiadiazine derivatives
0.000 0.981 0.019
Y49.9 Psychotropic drug, unspecified
0.000 0.981 0.019
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.981 0.019
Y49.7 Psychostimulants with abuse potential
0.000 0.981 0.019
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.981 0.019
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.981 0.019
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.981 0.019
H33.3 Retinal breaks without detachment
0.019 0.981 0.000
Y48.5 Therapeutic gases
0.000 0.981 0.019
Y48.1 Parenteral anaesthetics
0.000 0.981 0.019
Y48.0 Inhaled anaesthetics
0.000 0.981 0.019
Y54.7 Agents affecting calcification
0.000 0.981 0.019
Y58.9 Other and unspecified bacterial vaccines
0.000 0.982 0.018
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.982 0.018
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.982 0.018
Y58.5 Diphtheria vaccine
0.000 0.982 0.018
Y58.4 Tetanus vaccine
0.000 0.982 0.018
Y58.3 Plague vaccine
0.000 0.982 0.018
Y58.2 Cholera vaccine
0.000 0.982 0.018
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.982 0.018
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.982 0.018
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.982 0.018
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.982 0.018
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.982 0.018
Y47.4 Bromine compounds
0.000 0.982 0.018
Y47.3 Paraldehyde
0.000 0.982 0.018
Y47.2 Chloral derivatives
0.000 0.982 0.018
Y47.0 Barbiturates, not elsewhere classified
0.000 0.982 0.018
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.005 0.982 0.013
Y49.2 Other and unspecified antidepressants
0.000 0.982 0.018
Y54.9 Mineral salts, not elsewhere classified
0.000 0.982 0.018
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.982 0.018
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.982 0.018
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.982 0.018
Y54.8 Agents affecting uric acid metabolism
0.000 0.982 0.018
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.982 0.017
Y54.4 Loop [high-ceiling] diuretics
0.000 0.982 0.017
K31.9 Disease of stomach and duodenum, unspecified
0.017 0.983 0.000
Y50.9 Central nervous system stimulant, unspecified
0.000 0.983 0.017
Y50.8 Other central nervous system stimulants
0.000 0.983 0.017
Y50.1 Opioid receptor antagonists
0.000 0.983 0.017
Y50.0 Analeptics
0.000 0.983 0.017
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.983 0.017
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.983 0.017
Y54.0 Mineralocorticoids
0.000 0.983 0.017
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.983 0.016
Y59.0 Viral vaccines
0.000 0.984 0.016
H33 Retinal detachments and breaks
0.016 0.984 0.000
H33.2 Serous retinal detachment
0.016 0.984 0.000
Y48.4 Anaesthetic, unspecified
0.000 0.984 0.016
Y41.1 Antimycobacterial drugs
0.000 0.984 0.016
Y59.9 Vaccine or biological substance, unspecified
0.000 0.984 0.016
Y59.8 Other specified vaccines and biological substances
0.000 0.984 0.016
Y59.2 Protozoal vaccines
0.000 0.984 0.016
Y59.1 Rickettsial vaccines
0.000 0.984 0.016
Y53.6 Antidiarrhoeal drugs
0.000 0.984 0.015
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.985 0.015
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.985 0.015
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.985 0.015
Y53.7 Emetics
0.000 0.985 0.015
Y53.5 Digestants
0.000 0.985 0.015
Y53.0 Histamine H2-receptor antagonists
0.000 0.985 0.015
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.985 0.015
Y55.5 Anticommon cold drugs
0.000 0.985 0.015
Y55.3 Antitussives
0.000 0.985 0.015
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.985 0.015
Y55.0 Oxytocic drugs
0.000 0.985 0.015
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.985 0.015
Y41.4 Anthelminthics
0.000 0.985 0.015
Y41.3 Other antiprotozoal drugs
0.000 0.985 0.015
Y41.0 Sulphonamides
0.000 0.985 0.015
H33.4 Traction detachment of retina
0.015 0.985 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.986 0.014
Y57 Other and unspecified drugs and medicaments
0.000 0.986 0.014
H33.5 Other retinal detachments
0.014 0.986 0.000
Y53.3 Saline and osmotic laxatives
0.000 0.986 0.013
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.987 0.010
Y53.4 Other laxatives
0.000 0.987 0.013
H53 Visual disturbances
0.013 0.987 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.987 0.013
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.987 0.013
Y56.9 Topical agent, unspecified
0.003 0.987 0.010
Y56.8 Other topical agents
0.003 0.987 0.010
Y56.7 Dental drugs, topically applied
0.003 0.987 0.010
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.987 0.010
Y56.5 Ophthalmological drugs and preparations
0.003 0.987 0.010
Y56.2 Local astringents and local detergents
0.003 0.987 0.010
Y56.1 Antipruritics
0.003 0.987 0.010
Y46.8 Antispasticity drugs
0.000 0.987 0.013
Y46.3 Deoxybarbiturates
0.000 0.987 0.013
Y46.1 Oxazolidinediones
0.000 0.987 0.013
Y46.0 Succinimides
0.000 0.987 0.013
Y59.3 Immunoglobulin
0.000 0.987 0.013
Y46.7 Anti-Parkinsonism drugs
0.000 0.987 0.013
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.987 0.013
Y46.4 Iminostilbenes
0.000 0.987 0.013
M41.9 Scoliosis, unspecified
0.000 0.987 0.013
Y53.2 Stimulant laxatives
0.000 0.987 0.012
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.987 0.012
M41.94 Scoliosis, unspecified (Thoracic region)
0.000 0.988 0.012
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.000 0.988 0.012
Y54.5 Other diuretics
0.000 0.988 0.012
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.010 0.988 0.002
Y44 Agents primarily affecting blood constituents
0.000 0.988 0.012
H53.9 Visual disturbance, unspecified
0.012 0.988 0.000
Y46.5 Valproic acid
0.000 0.988 0.012
Y56.3 Emollients, demulcents and protectants
0.004 0.988 0.008
H53.4 Visual field defects
0.012 0.988 0.000
Y46.2 Hydantoin derivatives
0.000 0.988 0.011
Y55.4 Expectorants
0.000 0.988 0.011
Y46.6 Other and unspecified antiepileptics
0.000 0.989 0.011
H33.1 Retinoschisis and retinal cysts
0.011 0.989 0.000
M41.99 Scoliosis, unspecified (Site unspecified)
0.000 0.989 0.011
Y57.8 Other drugs and medicaments
0.000 0.989 0.011
Y57.6 Other diagnostic agents
0.000 0.989 0.011
H53.8 Other visual disturbances
0.011 0.989 0.000
Y57.7 Vitamins, not elsewhere classified
0.000 0.990 0.010
Y57.4 Pharmaceutical excipients
0.000 0.990 0.010
Y57.3 Alcohol deterrents
0.000 0.990 0.010
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.990 0.010
Y57.1 Lipotropic drugs
0.000 0.990 0.010
Y57.0 Appetite depressants [anorectics]
0.000 0.990 0.010
Y41.5 Antiviral drugs
0.000 0.990 0.010
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.000 0.990 0.010
M41.96 Scoliosis, unspecified (Lumbar region)
0.000 0.990 0.010
H53.6 Night blindness
0.010 0.990 0.000
H53.5 Colour vision deficiencies
0.010 0.990 0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.990 0.010
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.000 0.991 0.009
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.000 0.991 0.009
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.991 0.009
Y44.6 Natural blood and blood products
0.000 0.991 0.009
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.000 0.991 0.009
H53.3 Other disorders of binocular vision
0.009 0.991 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.991 0.009
Y44.7 Plasma substitutes
0.000 0.991 0.009
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.991 0.009
M41 Scoliosis
0.000 0.991 0.009
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.991 0.008
M41.92 Scoliosis, unspecified (Cervical region)
0.000 0.991 0.008
M41.8 Other forms of scoliosis
0.000 0.992 0.008
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.992 0.008
M41.86 Other forms of scoliosis (Lumbar region)
0.000 0.992 0.008
O64.0 Obstructed labour due to incomplete rotation of foetal head
0.007 0.993 0.000
Y44.5 Thrombolytic drugs
0.000 0.993 0.006
M41.4 Neuromuscular scoliosis
0.000 0.993 0.006
M41.3 Thoracogenic scoliosis
0.000 0.993 0.006
M41.2 Other idiopathic scoliosis
0.000 0.993 0.006
M41.1 Juvenile idiopathic scoliosis
0.000 0.993 0.006
M41.0 Infantile idiopathic scoliosis
0.000 0.993 0.006
K56.1 Intussusception
0.007 0.993 0.000
Y57.9 Drug or medicament, unspecified
0.000 0.993 0.006
M48.0 Spinal stenosis
0.000 0.993 0.006
F43.1 Posttraumatic stress disorder
0.006 0.994 0.000
M41.85 Other forms of scoliosis (Thoracolumbar region)
0.000 0.994 0.006
M41.89 Other forms of scoliosis (Site unspecified)
0.000 0.994 0.006
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)
0.000 0.994 0.006
M41.87 Other forms of scoliosis (Lumbosacral region)
0.000 0.994 0.006
M41.84 Other forms of scoliosis (Thoracic region)
0.000 0.994 0.006
M41.83 Other forms of scoliosis (Cervicothoracic region)
0.000 0.994 0.006
M41.82 Other forms of scoliosis (Cervical region)
0.000 0.994 0.006
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)
0.000 0.994 0.006
M41.80 Other forms of scoliosis (Multiple sites in spine)
0.000 0.994 0.006
M48.09 Spinal stenosis (Site unspecified)
0.000 0.994 0.006
K56.2 Volvulus
0.006 0.994 0.000
H33.0 Retinal detachment with retinal break
0.006 0.994 0.000
M41.5 Other secondary scoliosis
0.000 0.994 0.006
Y57.5 X-ray contrast media
0.000 0.994 0.005
Y43 Primarily systemic agents
0.000 0.994 0.006
G80.9 Infantile cerebral palsy, unspecified
0.006 0.994 0.000
H25.8 Other senile cataract
0.000 0.995 0.005
C69.3 Choroid
0.005 0.995 0.000
K01.1 Impacted teeth
0.000 0.995 0.005
Y40 Systemic antibiotics
0.000 0.995 0.005
M41.09 Infantile idiopathic scoliosis (Site unspecified)
0.000 0.995 0.005
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.995 0.005
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)
0.000 0.995 0.005
M41.06 Infantile idiopathic scoliosis (Lumbar region)
0.000 0.995 0.005
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)
0.000 0.995 0.005
M41.04 Infantile idiopathic scoliosis (Thoracic region)
0.000 0.995 0.005
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)
0.000 0.995 0.005
M41.02 Infantile idiopathic scoliosis (Cervical region)
0.000 0.995 0.005
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)
0.000 0.995 0.005
M41.19 Juvenile idiopathic scoliosis (Site unspecified)
0.000 0.995 0.005
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.995 0.005
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)
0.000 0.995 0.005
M41.16 Juvenile idiopathic scoliosis (Lumbar region)
0.000 0.995 0.005
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)
0.000 0.995 0.005
M41.14 Juvenile idiopathic scoliosis (Thoracic region)
0.000 0.995 0.005
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)
0.000 0.995 0.005
M41.12 Juvenile idiopathic scoliosis (Cervical region)
0.000 0.995 0.005
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)
0.000 0.995 0.005
M41.29 Other idiopathic scoliosis (Site unspecified)
0.000 0.995 0.005
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.995 0.005
M41.27 Other idiopathic scoliosis (Lumbosacral region)
0.000 0.995 0.005
M41.26 Other idiopathic scoliosis (Lumbar region)
0.000 0.995 0.005
M41.25 Other idiopathic scoliosis (Thoracolumbar region)
0.000 0.995 0.005
M41.24 Other idiopathic scoliosis (Thoracic region)
0.000 0.995 0.005
M41.23 Other idiopathic scoliosis (Cervicothoracic region)
0.000 0.995 0.005
M41.22 Other idiopathic scoliosis (Cervical region)
0.000 0.995 0.005
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M41.20 Other idiopathic scoliosis (Multiple sites in spine)
0.000 0.995 0.005
M41.39 Thoracogenic scoliosis-Site unspe
0.000 0.995 0.005
M41.38 Thoracogenic scoliosis-Sacral/sacrococ
0.000 0.995 0.005
M41.37 Thoracogenic scoliosis-Lumbosacral
0.000 0.995 0.005
M41.36 Thoracogenic scoliosis-Lumbar
0.000 0.995 0.005
M41.35 Thoracogenic scoliosis (Thoracolumbar region)
0.000 0.995 0.005
M41.34 Thoracogenic scoliosis (Thoracic region)
0.000 0.995 0.005
M41.33 Thoracogenic scoliosis (Cervicothoracic region)
0.000 0.995 0.005
M41.32 Thoracogenic scoliosis-Cervical
0.000 0.995 0.005
M41.31 Thoracogenic scoliosis-Occipit-atl-axl
0.000 0.995 0.005
M41.30 Thoracogenic scoliosis (Multiple sites in spine)
0.000 0.995 0.005
M41.49 Neuromuscular scoliosis (Site unspecified)
0.000 0.995 0.005
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)
0.000 0.995 0.005
M41.47 Neuromuscular scoliosis (Lumbosacral region)
0.000 0.995 0.005
M41.46 Neuromuscular scoliosis (Lumbar region)
0.000 0.995 0.005
M41.45 Neuromuscular scoliosis (Thoracolumbar region)
0.000 0.995 0.005
M41.44 Neuromuscular scoliosis (Thoracic region)
0.000 0.995 0.005
M41.43 Neuromuscular scoliosis (Cervicothoracic region)
0.000 0.995 0.005
M41.42 Neuromuscular scoliosis (Cervical region)
0.000 0.995 0.005
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M41.40 Neuromuscular scoliosis (Multiple sites in spine)
0.000 0.995 0.005
M48.03 Spinal stenosis (Cervicothoracic region)
0.000 0.995 0.005
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M48.05 Spinal stenosis (Thoracolumbar region)
0.000 0.995 0.005
K56.6 Other and unspecified intestinal obstruction
0.005 0.995 0.000
Z63.8 Other specified problems related to primary support group
0.000 0.995 0.005
K56 Paralytic ileus and intestinal obstruction without hernia
0.005 0.995 0.000
S30.1 Contusion of abdominal wall
0.000 0.996 0.004
M41.59 Other secondary scoliosis (Site unspecified)
0.000 0.996 0.004
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.57 Other secondary scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.55 Other secondary scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.53 Other secondary scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.52 Other secondary scoliosis (Cervical region)
0.000 0.996 0.004
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.50 Other secondary scoliosis (Multiple sites in spine)
0.000 0.996 0.004
Y43.9 Primarily systemic agent, unspecified
0.000 0.996 0.004
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.996 0.004
Y43.6 Enzymes, not elsewhere classified
0.000 0.996 0.004
Y43.5 Acidifying and alkalising agents
0.000 0.996 0.004
Y40.4 Tetracyclines
0.000 0.996 0.004
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
Y43.2 Antineoplastic natural products
0.000 0.996 0.004
G80 Infantile cerebral palsy
0.004 0.996 0.000
M48.04 Spinal stenosis (Thoracic region)
0.000 0.996 0.004
M41.56 Other secondary scoliosis (Lumbar region)
0.000 0.996 0.004
O64 Obstructed labour due to malposition and malpresentation of foetus
0.004 0.996 0.000
M41.54 Other secondary scoliosis (Thoracic region)
0.000 0.996 0.004
Z02.8 Other examinations for administrative purposes
0.000 0.996 0.004
Y40.2 Chloramphenicol group
0.000 0.996 0.004
O64.1 Obstructed labour due to breech presentation
0.004 0.996 0.000
N04.9 Unspecified
0.004 0.996 0.000
M70.22 Olecranon bursitis-Upper arm
0.004 0.996 0.000
G80.8 Other infantile cerebral palsy
0.004 0.996 0.000
M48.00 Spinal stenosis (Multiple sites in spine)
0.000 0.996 0.004
R73.9 Hyperglycaemia, unspecified
0.000 0.996 0.004
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.000 0.996 0.004
G80.0 Spastic cerebral palsy
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.000 0.996 0.003
I44.7 Left bundle-branch block, unspecified
0.000 0.996 0.004
Y43.1 Antineoplastic antimetabolites
0.000 0.996 0.004
G80.1 Spastic diplegia
0.004 0.996 0.000
Y40.6 Rifamycins
0.000 0.996 0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.996 0.004
Y40.3 Macrolides
0.000 0.996 0.003
Y40.7 Antifungal antibiotics, systemically used
0.000 0.996 0.003
C69 Malignant neoplasm of eye and adnexa
0.004 0.996 0.000
G80.2 Infantile hemiplegia
0.003 0.996 0.000
J43.9 Emphysema, unspecified
0.000 0.996 0.004
O64.3 Obstructed labour due to brow presentation
0.003 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.997 0.003
C69.6 Orbit
0.003 0.997 0.000
M10.99 Gout, unspecified (Site unspecified)
0.000 0.997 0.003
Y40.0 Penicillins
0.000 0.997 0.003
N30.2 Other chronic cystitis
0.000 0.997 0.003
G80.4 Ataxic cerebral palsy
0.003 0.997 0.000
G80.3 Dyskinetic cerebral palsy
0.003 0.997 0.000
K56.3 Gallstone ileus
0.003 0.997 0.000
M48.07 Spinal stenosis (Lumbosacral region)
0.000 0.997 0.003
K56.7 Ileus, unspecified
0.003 0.997 0.000
Y43.0 Antiallergic and antiemetic drugs
0.000 0.997 0.003
Y44.2 Anticoagulants
0.001 0.997 0.003
C69.0 Conjunctiva
0.003 0.997 0.000
M40-M43 Deforming dorsopathies
0.000 0.997 0.003
O64.5 Obstructed labour due to compound presentation
0.003 0.997 0.000
O64.4 Obstructed labour due to shoulder presentation
0.003 0.997 0.000
O64.2 Obstructed labour due to face presentation
0.003 0.997 0.000
S82.80 Fractures of other parts of lower leg (closed)
0.000 0.997 0.003
N60.4 Mammary duct ectasia
0.003 0.997 0.000
H53.0 Amblyopia ex anopsia
0.003 0.997 0.000
Y40.9 Systemic antibiotic, unspecified
0.002 0.997 0.001
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.997 0.003
S02.50 Fracture of tooth (closed)
0.000 0.997 0.003
C69.2 Retina
0.003 0.997 0.000
C69.8 Overlapping lesion of eye and adnexa
0.003 0.997 0.000
C69.5 Lachrymal gland and duct
0.003 0.997 0.000
C69.1 Cornea
0.003 0.997 0.000
E07.9 Disorder of thyroid, unspecified
0.003 0.997 0.000
M20.0 Deformity of finger(s)
0.003 0.997 0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified
0.003 0.997 0.000
C69.4 Ciliary body
0.003 0.997 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.003
S30 Superficial injury of abdomen, lower back and pelvis
0.000 0.997 0.003
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
C91.1 Chronic lymphocytic leukaemia
0.000 0.997 0.003
C91.5 Adult T-cell leukaemia
0.000 0.997 0.003
K56.5 Intestinal adhesions [bands] with obstruction
0.003 0.997 0.000
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts
0.003 0.997 0.000
Y40.8 Other systemic antibiotics
0.000 0.997 0.002
Z86.1 Personal history of infectious and parasitic diseases
0.003 0.997 0.000
M40 Kyphosis and lordosis
0.000 0.997 0.003
C54.1 Endometrium
0.000 0.997 0.003
O64.8 Obstructed labour due to other malposition and malpresentation
0.002 0.997 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.997 0.002
Y43.4 Immunosuppressive agents
0.000 0.997 0.002
M42 Spinal osteochondrosis
0.000 0.997 0.002
H16.0 Corneal ulcer
0.003 0.997 0.000
C91 Lymphoid leukaemia
0.000 0.997 0.003
K38.8 Other specified diseases of appendix
0.002 0.997 0.000
C91.4 Hairy-cell leukaemia
0.000 0.998 0.002
H53-H54 Visual disturbances and blindness
0.002 0.998 0.000
C91.9 Lymphoid leukaemia, unspecified
0.000 0.998 0.002
K56.0 Paralytic ileus
0.002 0.998 0.000
I20.1 Angina pectoris with documented spasm
0.000 0.998 0.002
I72.3 Aneurysm of iliac artery
0.002 0.998 0.000
S70.9 Superficial injury of hip and thigh, unspecified
0.000 0.998 0.002
I85.9 Oesophageal varices without bleeding
0.002 0.998 0.000
O24.4 Diabetes mellitus arising in pregnancy
0.002 0.998 0.000
C69.9 Eye, unspecified
0.002 0.998 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.998 0.002
M40.5 Lordosis, unspecified
0.000 0.998 0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.998 0.002
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.998 0.002
T46.7 Peripheral vasodilators
0.000 0.998 0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.998 0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.998 0.002
S06.20 Diffuse brain injury (without open intracranial wound)
0.000 0.998 0.002
T46.1 Calcium-channel blockers
0.000 0.998 0.002
M70.2 Olecranon bursitis
0.002 0.998 0.000
F43 Reaction to severe stress, and adjustment disorders
0.002 0.998 0.000
M34.8 Other forms of systemic sclerosis
0.002 0.998 0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis
0.000 0.998 0.002
Z12.1 Special screening examination for neoplasm of intestinal tract
0.002 0.998 0.000
N04 Nephrotic syndrome
0.002 0.998 0.000
F43.2 Adjustment disorders
0.002 0.998 0.000
M13.86 Other specified arthritis (Lower leg)
0.002 0.998 0.000
I27.2 Other secondary pulmonary hypertension
0.000 0.998 0.002
M40.4 Other lordosis
0.000 0.998 0.002
M40.3 Flatback syndrome
0.000 0.998 0.002
M40.1 Other secondary kyphosis
0.000 0.998 0.002
M40.0 Postural kyphosis
0.000 0.998 0.002
K51.0 Ulcerative (chronic) enterocolitis
0.002 0.998 0.000
K52.0 Gastro-enteritis and colitis due to radiation
0.000 0.998 0.002
K01 Embedded and impacted teeth
0.000 0.998 0.002
M40.56 Lordosis, unspecified (Lumbar region)
0.000 0.998 0.002
O12.1 Gestational proteinuria
0.002 0.998 0.000
E07.8 Other specified disorders of thyroid
0.002 0.998 0.000
M42.9 Spinal osteochondrosis, unspecified
0.000 0.998 0.002
M42.1 Adult osteochondrosis of spine
0.000 0.998 0.002
M42.0 Juvenile osteochondrosis of spine
0.000 0.998 0.002
C02.1 Border of tongue
0.002 0.998 0.000
M13.80 Other specified arthritis (Multiple sites)
0.002 0.998 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.998 0.002
C91.7 Other lymphoid leukaemia
0.000 0.998 0.002
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.998 0.002
C91.3 Prolymphocytic leukaemia
0.000 0.998 0.002
C91.2 Subacute lymphocytic leukaemia
0.000 0.998 0.002
M13.8 Other specified arthritis
0.002 0.998 0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)
0.000 0.998 0.002
M13.89 Other specified arthritis (Site unspecified)
0.002 0.998 0.000
M40.2 Other and unspecified kyphosis
0.000 0.998 0.002
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified
0.002 0.998 0.000
H53.1 Subjective visual disturbances
0.002 0.998 0.000
M13.83 Other specified arthritis (Forearm)
0.002 0.998 0.000
M40.59 Lordosis, unspecified (Site unspecified)
0.000 0.998 0.002
M40.58 Lordosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M40.57 Lordosis, unspecified (Lumbosacral region)
0.000 0.998 0.002
M40.55 Lordosis, unspecified (Thoracolumbar region)
0.000 0.998 0.002
M40.54 Lordosis, unspecified (Thoracic region)
0.000 0.998 0.002
M40.53 Lordosis, unspecified (Cervicothoracic region)
0.000 0.998 0.002
M40.52 Lordosis, unspecified (Cervical region)
0.000 0.998 0.002
M40.51 Lordosis, unspecified (Occipito-atlanto-axial region)
0.000 0.998 0.002
M40.50 Lordosis, unspecified (Multiple sites in spine)
0.000 0.998 0.002
M43 Other deforming dorsopathies
0.000 0.998 0.002
M34.1 CR(E)ST syndrome
0.002 0.998 0.000
N04.8 Other
0.002 0.998 0.000
C90.0 Multiple myeloma
0.000 0.998 0.002
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.998 0.002
M70.29 Olecranon bursitis-Site unspec
0.002 0.998 0.000
M70.28 Olecranon bursitis-Other
0.002 0.998 0.000
M70.27 Olecranon bursitis-Ankle/Foot
0.002 0.998 0.000
M70.26 Olecranon bursitis-Lower Leg
0.002 0.998 0.000
M70.25 Olecranon bursitis-Pelvic/Thigh
0.002 0.998 0.000
M70.24 Olecranon bursitis-Hand
0.002 0.998 0.000
M70.23 Olecranon bursitis-Forearm
0.002 0.998 0.000
M70.21 Olecranon bursitis-Shldr region
0.002 0.998 0.000
M70.20 Olecranon bursitis-Mult sites
0.002 0.998 0.000
E04.1 Non-toxic single thyroid nodule
0.000 0.998 0.002
F43.8 Other reactions to severe stress
0.002 0.998 0.000
K56.4 Other impaction of intestine
0.002 0.998 0.000
S30.0 Contusion of lower back and pelvis
0.000 0.998 0.002
E07 Other disorders of thyroid
0.002 0.998 0.000
M40.24 Other and unspecified kyphosis (Thoracic region)
0.000 0.998 0.002
S62.60 Fracture of other finger (closed)
0.002 0.998 0.000
N04.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
N04.0 Minor glomerular abnormality
0.002 0.998 0.000
O24.9 Diabetes mellitus in pregnancy, unspecified
0.002 0.998 0.000
S06.80 Other intracranial injuries (without open intracranial wound)
0.000 0.998 0.002
N04.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N04.6 Dense deposit disease
0.002 0.998 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
M40.09 Postural kyphosis (Site unspecified)
0.000 0.998 0.002
M40.08 Postural kyphosis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M40.07 Postural kyphosis (Lumbosacral region)
0.000 0.998 0.002
M40.06 Postural kyphosis (Lumbar region)
0.000 0.998 0.002
M40.05 Postural kyphosis (Thoracolumbar region)
0.000 0.998 0.002
M40.04 Postural kyphosis (Thoracic region)
0.000 0.998 0.002
M40.03 Postural kyphosis (Cervicothoracic region)
0.000 0.998 0.002
M40.02 Postural kyphosis (Cervical region)
0.000 0.998 0.002
M40.01 Postural kyphosis (Occipito-atlanto-axial region)
0.000 0.998 0.002
M40.00 Postural kyphosis (Multiple sites in spine)
0.000 0.998 0.002
M40.19 Other secondary kyphosis (Site unspecified)
0.000 0.998 0.002
M40.18 Other secondary kyphosis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M40.17 Other secondary kyphosis (Lumbosacral region)
0.000 0.998 0.002
M40.16 Other secondary kyphosis (Lumbar region)
0.000 0.998 0.002
M40.15 Other secondary kyphosis (Thoracolumbar region)
0.000 0.998 0.002
M40.14 Other secondary kyphosis (Thoracic region)
0.000 0.998 0.002
M40.13 Other secondary kyphosis (Cervicothoracic region)
0.000 0.998 0.002
M40.12 Other secondary kyphosis (Cervical region)
0.000 0.998 0.002
M40.11 Other secondary kyphosis (Occipito-atlanto-axial region)
0.000 0.998 0.002
M40.10 Other secondary kyphosis (Multiple sites in spine)
0.000 0.998 0.002
M40.39 Flatback syndrome (Site unspecified)
0.000 0.998 0.002
M40.38 Flatback syndrome (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M40.37 Flatback syndrome (Lumbosacral region)
0.000 0.998 0.002
M40.36 Flatback syndrome (Lumbar region)
0.000 0.998 0.002
M40.35 Flatback syndrome (Thoracolumbar region)
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.